Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma

Investigational New Drugs
Elisabeth I HeathArlene A Forastiere

Abstract

This randomized phase II, parallel-design study evaluated preoperative combined modality therapy and the matrix metalloprotease (MMP) inhibitor prinomastat in patients with resectable adenocarcinoma of the esophagus that were stage II or greater. The objectives of the trial were to determine pathologic complete response rate (pCR), overall response rate, progression-free survival, pattern of disease relapse, and two-year and overall survival. Preoperative staging included computed tomography, endoscopic ultrasound, and, when feasible, laparoscopy. Eligible patients were randomized to preoperative prinomastat or placebo, plus continuous infusion 5-FU, cisplatin, paclitaxel, and concurrent radiotherapy. Esophagectomy was performed on day 71. Adjuvant paclitaxel and prinomastat were available to all study patients. Between August 2000 and June 2001, 15 of a planned 78 patients were randomized into the trial. One patient after randomization withdrew consent. Fourteen patients, 7 in each arm, completed preoperative treatment and surgery. pCR was achieved in 5 patients; 1/ 7 prinomastat and 4/ 7 placebo. Disease improvement was achieved in 7 patients; 5 /7 prinomastat and 2 /7 placebo. At a median follow-up of 28 months, 7 patients (...Continue Reading

References

Sep 1, 1978·The Annals of Thoracic Surgery·R A Cukingnan, J S Carey
Mar 1, 1989·Controlled Clinical Trials·R Simon
Sep 1, 1988·Current Problems in Cancer·T R DeMeester, A P Barlow
Jan 1, 1993·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·H Birkedal-HansenJ A Engler
Sep 18, 1997·Journal of the National Cancer Institute·A F Chambers, L M Matrisian
Oct 15, 1998·The Journal of Pathology·G I MurrayJ E Fothergill
Feb 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·E I HeathA A Forastiere
Mar 16, 2000·Drugs·A H van MilG J Blauw
Jun 20, 2000·Surgical Endoscopy·E I HeathA A Forastiere
Nov 6, 2002·Journal of Assisted Reproduction and Genetics·Stephen J Fortunato, Ramkumar Menon
Jan 1, 2003·American Journal of Hematology·Douglas E SutherlandHoward A Liebman
May 10, 2003·International Journal of Radiation Oncology, Biology, Physics·Lawrence KleinbergArlene A Forastiere

❮ Previous
Next ❯

Citations

Jan 29, 2008·Cancer Metastasis Reviews·K N SyrigosMuhammad Wasif Saif
Jan 9, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Christopher ChristophiTheodora Fifis
Jun 30, 2010·Carcinogenesis·Nicholas J ClemonsRebecca C Fitzgerald
Oct 22, 2008·ORL; Journal for Oto-rhino-laryngology and Its Related Specialties·Joni B SkipperDonald J Buchsbaum
Nov 1, 2009·Therapeutic Advances in Medical Oncology·D G Power, D H Ilson
Nov 16, 2007·Arthritis Research & Therapy·Yvonne RengelSteffen Gay
Jan 14, 2012·Expert Opinion on Therapeutic Targets·María Villa-Morales, José Fernández-Piqueras
Dec 17, 2008·Expert Review of Gastroenterology & Hepatology·Jurjen J BoonstraLinetta B Koppert
Apr 28, 2009·Surgical Oncology·Slavica KvolikLjubica Glavas-Obrovac
Mar 17, 2009·Best Practice & Research. Clinical Haematology·Francesca EliceFrederick R Rickles
Oct 31, 2008·ANZ Journal of Surgery·Lie S ChanChristopher Christophi
Sep 27, 2008·American Journal of Hematology·Francesca EliceFrancesco Rodeghiero
Oct 21, 2004·Best Practice & Research. Clinical Haematology·Elihu H Estey
Mar 31, 2009·Gastroenterology Clinics of North America·Geoffrey Y Ku, David H Ilson
Jun 30, 2010·International Journal of Radiation Oncology, Biology, Physics·Richard V ScheerPeter A S Johnstone
Jan 9, 2008·Seminars in Hematology·Magda Melchert, Alan List
Aug 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maurizio ZangariGuido J Tricot
Sep 15, 2010·Expert Review of Anticancer Therapy·Piet DirixSandra Nuyts
Jun 22, 2013·The International Journal of Biological Markers·Wenzhao LiMasakazu Toi
May 8, 2018·Molecular Cancer Therapeutics·Arthur WinerPaolo Mignatti
Jan 6, 2021·Pharmaceuticals·Nabangshu DasAntoine Dufour
Jun 23, 2021·European Journal of Medicinal Chemistry·Sanjib DasTarun Jha
Aug 18, 2021·Journal of Biomolecular Structure & Dynamics·Plaboni SenSiddhartha Sankar Ghosh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.